Cabaletta Bio (CABA) EPS (Basic) (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.45% |
| Sep 30, 2025 | 39.73% |
| Jun 30, 2025 | -2.82% |
| Mar 31, 2025 | -9.23% |
| Dec 31, 2024 | -4.84% |
| Sep 30, 2024 | -10.71% |
| Jun 30, 2024 | -9.80% |
| Mar 31, 2024 | -8.51% |
| Dec 31, 2023 | -27.03% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 17.78% |
| Mar 31, 2023 | 13.46% |
| Dec 31, 2022 | -33.33% |
| Sep 30, 2022 | 13.33% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 8.16% |
| Dec 31, 2021 | -8.89% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | -9.76% |
| Mar 31, 2021 | -17.14% |
| Dec 31, 2020 | 2.78% |
| Sep 30, 2020 | -2.86% |
| Jun 30, 2020 | -6.06% |
| Mar 31, 2020 | -106.26% |
| Dec 31, 2019 | 342.86% |
| Sep 30, 2019 | -16.04% |
| Jun 30, 2019 | 69.09% |
| Mar 31, 2019 | -323.08% |
| Dec 31, 2018 | 84.90% |